Azucena Meraz, is a
Peer Specialist based in Medford, Oregon. Azucena Meraz is licensed to practice in Oregon (license number ) and her current practice location is
2762 High Cedars Ln, Medford, Oregon. She can be reached at her office (for appointments etc.) via phone at
(458) 226-6282.
NPI number for Azucena Meraz is 1184587750 and her current mailing address is 2762 High Cedars Ln, Medford, Oregon. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1184587750.
Healthcare Provider's Profile
| Full Name | Azucena Meraz |
|---|
| Gender | Female |
|---|
| Speciality | Peer Specialist |
|---|
| Location | 2762 High Cedars Ln, Medford, Oregon |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1184587750
- Provider Enumeration Date: 12/09/2025
- Last Update Date: 01/22/2026
Medical Identifiers
Medical identifiers for Azucena Meraz such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1184587750 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (Oregon) | Secondary |
| 175T00000X | Peer Specialist | (Oregon) | Primary |
| 101YM0800X | Counselor - Mental Health | (Oregon) | Secondary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Azucena Meraz is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Azucena Meraz, 2762 High Cedars Ln, Medford, OR 97504-3416 Ph: () - | Azucena Meraz, 2762 High Cedars Ln, Medford, OR 97504-3416 Ph: (458) 226-6282 |
Reviews and Comments